News
TMDX
68.86
+1.49%
1.01
3 Growth Stocks to Buy on the Dip
NASDAQ · 2d ago
3 Most Shorted Stocks with Up to 275% Upside Potential
TipRanks · 3d ago
TransMedics Group Price Target Maintained With a $120.00/Share by TD Cowen
Dow Jones · 3d ago
TD Cowen Reiterates Buy on TransMedics Group, Maintains $120 Price Target
Benzinga · 3d ago
Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX) and Evolus (EOLS)
TipRanks · 3d ago
TransMedics: The Margins Must Recover
Seeking Alpha · 3d ago
TransMedics benefiting from growth in heart transplant volumes, says TD Cowen
TipRanks · 4d ago
TransMedics Group Is Maintained at Buy by Canaccord Genuity
Dow Jones · 4d ago
TransMedics Group Price Target Maintained With a $124.00/Share by Canaccord Genuity
Dow Jones · 4d ago
Analyst Maintains Buy on TransMedics, Keeps Price Target Unchanged at $124 Despite Higher Interest Costs and Dilution
TipRanks · 5d ago
Noteworthy Monday Option Activity: OSUR, TMDX, DSP
NASDAQ · 5d ago
Weekly Report: what happened at TMDX last week (0622-0626)?
Weekly Report · 6d ago
Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Aquestive Therapeutics (AQST) and Alto Neuroscience, Inc. (ANRO)
TipRanks · 06/26 12:30
10 mid-cap U.S. healthcare stocks with the weakest momentum grades
Seeking Alpha · 06/24 14:10
Weekly Report: what happened at TMDX last week (0615-0619)?
Weekly Report · 06/22 09:55
Stifel Nicolaus Sticks to Their Hold Rating for TransMedics Group (TMDX)
TipRanks · 06/22 02:15
TransMedics Group Is Maintained at Hold by Stifel
Dow Jones · 06/18 12:51
TransMedics Group Price Target Raised to $80.00/Share From $75.00 by Stifel
Dow Jones · 06/18 12:51
Stifel Maintains Hold on TransMedics Group, Raises Price Target to $80
Benzinga · 06/18 12:40
TransMedics price target raised to $80 from $75 at Stifel
TipRanks · 06/18 10:42
More
Webull provides a variety of real-time TMDX stock news. You can receive the latest news about Transmedics Group through multiple platforms. This information may help you make smarter investment decisions.
About TMDX
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.